PRESS RELEASES Coming soon. SLIDESHOWS |
IN THE NEWS The other side of the hormone controversy Could doctors have been wrong about hormones -- again? In 2002, the authors of a large-scale study, the Women's Health Initiative, set off panicky newspaper headlines by proclaiming that the risks incurred by women taking hormones outweighed the potential benefits. Many women and their doctors concluded that it was best to discontinue hormone therapy or use it only in the short term if menopausal symptoms were unbearable. Read more >> Pfizer Wyeth merger worries PMU producers An agreement that will see pharmaceutical giant Pfizer take over rival company Wyeth for $68 billion has caused some uncertainty for pregnant mare’s urine producers in Sask, Man. and in North Dakota.Norm Luba , executive director of The North American Equine Ranching Information Council (NAERIC) said there are 71 PMU farms in Western Canada and the northern United states — 15 in Saskatchewan, 53 in Manitoba and 3 in North Dakota. Roughly 5,600 brood mares are involved in PMU production. Luba said it is too early to assess the impact of the Pfizer-Wyeth takeover, which was announced Jan. 26. Read more >> WHI says estrogen HRT drugs still too hot to handleIt was the report by the Women’s Health Initiative that
the dangers (our words) of hormone replacement therapy drugs for the
treatment of symptoms of menopause outweighed any benefits that started
the downward spiral (and upward spiral of later lawsuits) of pharmas
like the Premarin (R) family of drugs manufactured by Wyeth. |
